ANALOGS OF TETRAHYDROFOLIC ACID. XV. MODE OF BINDING OF 2,4-DIAMINOPYRIMIDINES TO FOLIC REDUCTASE AND THYMIDYLATE SYNTHETASE.

B. R. Baker,B. Ho
DOI: https://doi.org/10.1002/JPS.2600531206
1964-12-01
Journal of Pharmacy and Science
Abstract:A series of compounds related to 5-(3-anilinopropyl)-2,4-diamino 6-methyl-4-pyrimidine (XIII) was synthesized and evaluated as inhibitors of dihydrofolic reductase and thymidylate synthetase. Strong evidence was obtained that both amino groups were binding groups to both enzymes. Inhibition by 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol (I b ) was lost with both enzymes when the 2-amino group was replaced by 2-dimethylamino (XXII). When the 4-amino group of XIII was replaced by a 4-dimethylamino, a 26-fold decrease in binding to dihydrofolic reductase was observed. In contrast, this structural change caused little change in the extent of inhibition of thymidylate synthetase. The 2-amino group of I b probably binds to both enzymes (E) through an N─H ← E hydrogen bond. The 4-hydroxyl group of I b probably binds to dihydrofolic reductase by an O─H ← E hydrogen bond of the less favored 4-hydroxy tautomer but to thymidylate synthetase by a C=O → H─E hydrogen bond of the more stable 4-oxo tautomer. Since 2,4-diaminopteridines bind to folic reductase 10 to fiftyfold stronger than similarly substituted 2,4-diamino-5,6-dialkylpyrimidines, it is probable that N 5 or N 8 of the pteridine is an additional binding group. In contrast, 2-amino-4-hydroxy-5,6-dialkylpyrimidines bind to folic reductase about fivefold better than the corresponding 2-amino-4-hydroxypteridines, an indication that neither N 5 nor N 8 of the latter is a binding group. It is proposed that the imidazole ring of a histidine is present in the active site of folic reductase in order to transfer a proton to one side of a pyrazine double bond when hydride ion is transferred from TPNH to the other side of the double bond. It is also proposed that this imidazole ring forms a complex ( a ) with N 5 or N 8 of 2,4-diaminopteridines, ( b ) with a 6-phenyl or 6-benzyl group attached to a 2-amino-4-pyrimidinol, or ( c ) with a 5-phenyl group attached to a 2,4-diaminopyrimidine.
What problem does this paper attempt to address?